Physician profile
Luigi Querusio
NPI 1497861868
$1,684.91
in general payments reported to CMS, 2019-2025
23 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $152 · 2021: $229 · 2022: $201 · 2023: $266 · 2024: $268 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $170.50 | 2022-2023 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $170.26 | 2023-2025 | Biofix, Biodoptix, Medihoney |
| Smith+Nephew, INC. | $162.52 | 2020-2022 | |
| Acera Surgical, INC. | $146.58 | 2024 | Restrata Wound Matrix |
| Heron Therapeutics, INC. | $136.91 | 2021-2025 | Zynrelef |
| Baxter Healthcare | $119.27 | 2021-2025 | Floseal, Perclot |
| Davol INC. | $117.65 | 2021-2025 | Phasix Mesh, Arista |
| Kci USA, INC. | $84.94 | 2019-2021 | |
| Reprise Biomedical, INC. | $74.64 | 2023 | Miro3d |
| Kerecis Limited | $71.38 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Innocoll Pharmaceuticals Limited | $65.14 | 2021-2022 | |
| Solventum Corporation | $56.46 | 2024-2025 | Prevena |
| Portola Pharmaceuticals, LLC | $52.21 | 2019 | |
| Allergan, INC. | $50.38 | 2019-2020 | |
| Tela Bio, INC. | $40.99 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $29.26 | 2020 | |
| Penumbra, INC. | $26.67 | 2019 | |
| Microvention, INC. | $24.49 | 2019 | |
| Coloplast Corp | $21.04 | 2025 | |
| Conmed Corporation | $18.90 | 2023 | Airseal |
| Kowa Pharmaceuticals America, INC. | $15.57 | 2022 | |
| Mallinckrodt Enterprises LLC | $15.28 | 2019 | |
| Covidien LP | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luigi Querusio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.